~3.1 billion
base pairs
A haploid nuclear reference is about three billion DNA letters long; exact totals depend on the assembly.
Human genome
A human genome is both a biological sequence and a coordinate system for research. This guide separates established facts, changing reference assemblies and interpretation limits.
Genome at a glance
The genome is not a list of genes. It is a layered system of coding sequence, regulatory elements, repeats, structural regions and mitochondrial DNA.
~3.1 billion
A haploid nuclear reference is about three billion DNA letters long; exact totals depend on the assembly.
23 pairs
Humans normally carry 22 pairs of autosomes and one pair of sex chromosomes, plus a small mitochondrial genome.
<2%
Most sequence does not encode protein. Regulatory, structural, repetitive and still-uncertain regions are biologically important.
99.9%+
Human genomes are overwhelmingly similar, but millions of inherited and new variants make each genome distinct.
Genes and transcripts sit within regulatory DNA, repetitive elements, centromeres, telomeres and large structural segments.
A reference assembly is not a universal or ideal human genome. It is a versioned scaffold used to name coordinates and compare observations.
Single-nucleotide changes, indels, copy-number and structural variants require population, family, tissue and phenotype evidence.
History
The Human Genome Project was an international public consortium, not the work of one person or one laboratory.
1988–1990
The U.S. National Research Council endorsed a coordinated program; NIH and DOE launched the Human Genome Project in 1990.
1996
The Bermuda Principles established rapid public release of large-scale sequence data, shaping open genomic science.
2000–2001
The international public consortium announced a working draft; its analysis appeared in Nature in 2001.
2003
The project announced a finished essential sequence, covering about 99% of gene-containing regions at 99.99% accuracy.
2013–2022
GRCh38 became the major coordinate reference; the Telomere-to-Telomere consortium later completed previously unresolved regions with T2T-CHM13.
2023 onward
The Human Pangenome Reference Consortium began representing global diversity with many high-quality, phased assemblies rather than one linear genome.
People and collaboration
Thousands of researchers at 20 sequencing centres across six countries contributed. The names below help orient the history; they do not replace the consortium credit.
First director of the U.S. National Center for Human Genome Research, 1989–1992.
Led the U.S. public genome program from 1993 through completion of the Human Genome Project.
Led the Wellcome Trust Sanger Centre contribution and advocated rapid, public sequence release.
Major leaders of public sequencing centres and consortium analysis.
Directed the U.S. Department of Energy genome program during key project years.
Led a separate private-sector draft effort; important historically, but distinct from the international public consortium.
Reference generations
These resources answer different questions. Liftover between assemblies can fail or change meaning, so never omit the assembly name.
The Genome Reference Consortium assembly widely used in annotation and clinical/research pipelines. Coordinates are assembly-specific and must always be reported with the assembly version.
Official or primary sourceA near-complete haploid assembly that resolved centromeres, segmental duplications and other regions missing from earlier references. The original CHM13 assembly covered autosomes and X, not Y.
Official or primary sourceA graph-aware, multi-assembly resource designed to reduce reference bias and represent sequence and structural diversity across populations.
Official or primary sourceDetailed analysis
A responsible workflow keeps identity, evidence, uncertainty and provenance visible from beginning to end.
Define phenotype, population, tissue, inheritance model and the question before opening a database.
Record genome assembly, chromosome, position, reference and alternate alleles. Normalize the variant.
Map genes, transcripts, consequence, frequency, conservation and regulatory context using versioned sources.
Check population frequencies, phenotype databases, functional evidence and primary literature. Avoid treating prediction as proof.
Confirm technical quality and, where required, use an independent validated laboratory method.
Preserve provenance, access dates, software/database versions, uncertainty and limitations. Protect participant privacy.
A computational score is a hypothesis-support tool, not a diagnosis. Absence from a database is not evidence of harmlessness; correlation is not causation; ancestry imbalance can distort frequency estimates; and reference bias can hide structural diversity. Clinical classification requires accredited workflows, current professional standards and qualified specialists.
Ethics and ELSI
Consent, privacy, governance and equitable representation are scientific quality requirements.
It does not interpret a person’s genome, establish pathogenicity, recommend care or replace genetic counselling. It is a research and education map to primary sources.
Sources
Access dates and database releases should be recorded in every research report.
NHGRI
NHGRI
International Human Genome Sequencing Consortium, Nature (2001)
NCBI/GRC
Nurk et al., Science (2022)
Liao et al., Nature (2023)
NHGRI
Ensembl